SCHEMBL663775

SCHEMBL663775

CCOC(=O)C(CC)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 3/20 0.43
GAA P10253 2/20 0.42
ALOX15 P16050 1/20 0.42
MGAM O43451 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
SOAT1 P35610 1/20 0.42
MMP8 P22894 1/20 0.42
PIN1 Q13526 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TRPA1 O75762 1/20 0.39
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.37
RECQL P46063 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9430104 0.97 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10TDP1GAA
SCHEMBL230068 0.89 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10TDP1GAA
P-Xylene SCHEMBL28753787 0.87 MEN1 (0.56) ALDH1A1TDP1GAAMMP8PIN1
SCHEMBL26658212 0.86 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TDP1GAA
Hydrochloric Acid SCHEMBL27522636 0.86 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TDP1GAA
SCHEMBL28077349 0.86 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TDP1GAA
SCHEMBL28054134 0.86 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TDP1GAA
Ammonia Solution, Strong SCHEMBL27830684 0.86 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TDP1GAA
SCHEMBL14193603 0.86 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10TDP1GAA
SCHEMBL30371946 0.84 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236710-A1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE COVEME S.P.A. (IT) 2025-07-24 US claimed
EP-4422863-B1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE TECHNICAL FIELD COVEME S P A (IT) 2025-03-26 EP claimed
US-20240429341-A1 METHOD FOR FORMING A PHOTOVOLTAIC MODULE COVEME S.P.A. (IT) 2024-12-26 US claimed
EP-4422862-A1 METHOD FOR FORMING A PHOTOVOLTAIC MODULE Coveme S.p.A. (IT) 2024-09-04 EP claimed
EP-4422863-A1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE Coveme S.p.A. (IT) 2024-09-04 EP claimed
WO-2023073627-A1 METHOD FOR FORMING A PHOTOVOLTAIC MODULE COVEME S.P.A. (IT) 2023-05-04 WO claimed
WO-2023073628-A1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE COVEME S.P.A. (IT) 2023-05-04 WO claimed
CN-105111155-B A kind of synthetic method of 4,7- diaza spiro [2.5] octane -7- t-butyl formate 武汉工程大学 2018-12-14 CN claimed
US-6415614-B1 CONTROLLING VAPOR PRESSURE OF MIXTURE VISTEON GLOBAL TECHNOLOGIES, INC. 2002-07-09 US claimed
US-12637680-B2 Recombinant host cells for the production of malonate LYGOS, INC. (US) 2026-05-26 US disclosed
US-20250236710-A1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE COVEME S.P.A. (IT) 2025-07-24 US disclosed
EP-4388138-B1 CONDENSATES, A PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS RE-TANNING AGENTS STAHL INT B V (NL) 2025-05-28 EP disclosed
EP-4422863-B1 INTERMEDIATE FILM FOR A PHOTOVOLTAIC MODULE, METHOD FOR FORMING SAME AND METHOD FOR FORMING A PHOTOVOLTAIC MODULE TECHNICAL FIELD COVEME S P A (IT) 2025-03-26 EP disclosed
WO-2025049964-A1 BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2025-03-06 WO disclosed
EP-0046590-A2 Phen(alk)oxy-substituted oxirane-carboxylic acids, process for their preparation, their use and drugs containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1982-03-03 EP disclosed
US-4267174-A AND PROCESS FOR ADMINISTERING BOEHRINGER MANNHEIM, GMBH (DE) 1981-05-12 US disclosed
US-3997682-A Oleaginous food flavored with certain alpha carboxy acids and/or esters thereof ANDERSON, CLAYTON & CO. (US) 1976-12-14 US disclosed
US-3960906-A INSECTICIDES SANDOZ LTD. (CH) 1976-06-01 US disclosed
US-3935271-A INSECTICIDE SANDOZ LTD. (CH) 1976-01-27 US disclosed
US-3932483-A INSECTICIDES SANDOZ LTD., (SANDOZ AG) (CH) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637680-B2 Recombinant host cells for the production of malonate DCXR, ETV1, LYPLA2 ALDH1A1 1554/4885LMNA 4287/4885HSD17B10 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.